Dr. Ferreira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
508 South Habana Avenue
Suite 340
Tampa, FL 33609Phone+1 813-873-7367Fax+1 813-875-9722- Is this information wrong?
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Child Neurology, 1990 - 1993
- Yale-New Haven Medical CenterResidency, Pediatrics, 1988 - 1990
- Universidad Central del Este Facultad de MedicinaClass of 1986
Certifications & Licensure
- FL State Medical License 1994 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense Start of enrollment: 2011 Oct 01
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Start of enrollment: 2023 Aug 16
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsSafety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trialJose A. Ferreira, Jean-Baptiste Le Pichon, Ahmed Abdelmoity, Deanne Dilley, Peter Dedeken, Tony Daniels, William C. Byrnes> ;Seizure. 2019 Oct 1
- 22 citationsExploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.Manuel Neves, Rita Azevedo, Luís Lima, Marta I. Oliveira, Andreia F. Peixoto, Dylan Ferreira, Janine Soares, Elisabete Fernandes, Cristiana Gaiteiro, Carlos M. Palmeir...> ;New Biotechnology. 2019 Mar 25
- 22 citationsAdjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy:J. Ben Renfroe, Mark Mintz, Ronald W. Davis, Jose A. Ferreira, Sharon Dispoto, Jim Ferry, Yuko Umetsu, Bhaskar Rege, Oneeb Majid, Ziad Hussein, Antonio Laurenza> ;Journal of Child Neurology. 2019 Feb 10
- Join now to see all
Press Mentions
- LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy PatientsAugust 24th, 2018
Hospital Affiliations
- Tampa General HospitalTampa, Florida
- St. Joseph's HospitalTampa, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: